These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 35777588)

  • 1. Resveratrol and resveratrol nano-delivery systems in the treatment of inflammatory bowel disease.
    Gowd V; Kanika ; Jori C; Chaudhary AA; Rudayni HA; Rashid S; Khan R
    J Nutr Biochem; 2022 Nov; 109():109101. PubMed ID: 35777588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol and inflammatory bowel disease: the evidence so far.
    Nunes S; Danesi F; Del Rio D; Silva P
    Nutr Res Rev; 2018 Jun; 31(1):85-97. PubMed ID: 29191255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol and inflammatory bowel disease.
    Shi Y; Zhou J; Jiang B; Miao M
    Ann N Y Acad Sci; 2017 Sep; 1403(1):38-47. PubMed ID: 28945937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polyphenols in the treatment of inflammatory bowel diseases].
    Chojnacka K; Laskowska J
    Postepy Biochem; 2020 Sep; 66(3):256-262. PubMed ID: 33315320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of natural product-delivering micro/nano systems in the treatment of inflammatory bowel disease.
    Zhou Y; Feng X; Xu H; Guo J; Yang C; Kong L; Zhang Z
    J Mater Chem B; 2023 Jan; 11(2):244-260. PubMed ID: 36512384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
    Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
    Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyphenol supplementation as a complementary medicinal approach to treating inflammatory bowel disease.
    Biasi F; Astegiano M; Maina M; Leonarduzzi G; Poli G
    Curr Med Chem; 2011; 18(31):4851-65. PubMed ID: 21919842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An oral polyphenol host-guest nanoparticle for targeted therapy of inflammatory bowel disease.
    Zhang C; Zeng F; Fan Z; He Z; Tai L; Peng Q; Zhang Y; Chao Z; Jiang W; Jia L; Han L
    Acta Biomater; 2023 Oct; 169():422-433. PubMed ID: 37597682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulus-responsive drug delivery nanoplatforms for inflammatory bowel disease therapy.
    Long J; Liang X; Ao Z; Tang X; Li C; Yan K; Yu X; Wan Y; Li Y; Li C; Zhou M
    Acta Biomater; 2024 Oct; 188():27-47. PubMed ID: 39265673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol Attenuates Inflammatory Bowel Disease in Mice by Regulating SUMO1.
    Wang J; Zhang Z; Fang A; Wu K; Chen X; Wang G; Mao F
    Biol Pharm Bull; 2020; 43(3):450-457. PubMed ID: 32115503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation of Polyphenolic Compounds Based on Hemicelluloses to Enhance Treatment of Inflammatory Bowel Diseases and Colorectal Cancer.
    Caban M; Lewandowska U
    Molecules; 2023 May; 28(10):. PubMed ID: 37241929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential interventions and interactions of bioactive polyphenols and functional polysaccharides to alleviate inflammatory bowel disease - A review.
    Farid MS; Shafique B; Xu R; Łopusiewicz Ł; Zhao C
    Food Chem; 2025 Jan; 462():140951. PubMed ID: 39213975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats.
    Lozano-Pérez AA; Rodriguez-Nogales A; Ortiz-Cullera V; Algieri F; Garrido-Mesa J; Zorrilla P; Rodriguez-Cabezas ME; Garrido-Mesa N; Utrilla MP; De Matteis L; de la Fuente JM; Cenis JL; Gálvez J
    Int J Nanomedicine; 2014; 9():4507-20. PubMed ID: 25285004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on curcumin colon-targeted oral drug delivery systems for the treatment of inflammatory bowel disease.
    Sardou HS; Vosough PR; Abbaspour M; Akhgari A; Sathyapalan T; Sahebkar A
    Inflammopharmacology; 2023 Jun; 31(3):1095-1105. PubMed ID: 36757584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapeutic targets for inflammatory bowel disease.
    Argollo M; Fiorino G; Hindryckx P; Peyrin-Biroulet L; Danese S
    J Autoimmun; 2017 Dec; 85():103-116. PubMed ID: 28711286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary Supplementation with Vitamin D, Fish Oil or Resveratrol Modulates the Gut Microbiome in Inflammatory Bowel Disease.
    Wellington VNA; Sundaram VL; Singh S; Sundaram U
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel agents in the future: Therapy beyond anti-TNF agents in inflammatory bowel disease.
    Peng JC; Shen J; Ran ZH
    J Dig Dis; 2014 Nov; 15(11):585-90. PubMed ID: 25251263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts.
    Zhu X; Liu Q; Wang M; Liang M; Yang X; Xu X; Zou H; Qiu J
    PLoS One; 2011; 6(11):e27081. PubMed ID: 22069489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.
    Yang C; Merlin D
    Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol-loaded nanomedicines for cancer applications.
    Annaji M; Poudel I; Boddu SHS; Arnold RD; Tiwari AK; Babu RJ
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1353. PubMed ID: 33655717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.